Loading organizations...
§ Private Profile · Tokyo, Tokyo, Japan
Develops digital therapeutics, including a mobile app for migraine and headache treatment, and offers corporate health management services.
Hedgehog MedTech develops digital therapeutics, primarily a mobile application designed for the treatment of migraine and headache using Cognitive Behavioral Therapy (CBT). This innovative approach offers a simple, effective non-drug alternative to traditional symptomatic treatments, such as analgesics, aiming to significantly improve patient outcomes and daily functioning. The company also intends to extend its offerings to provide comprehensive health management services for corporate entities, with a strategic focus on enhancing employee quality of life and overall workplace productivity. Operating within the burgeoning digital therapeutics sector, Hedgehog MedTech specifically targets neurological conditions like migraines and chronic headaches. CEO and Founder Yumi Kawata brings substantial industry experience, having previously served as a healthcare investment manager at SoftBank and a government relations specialist at Medley. Hedgehog MedTech was established in October 2021 by Yumi Kawata.
Hedgehog MedTech has raised $4.4M across 2 funding rounds.
Hedgehog MedTech has raised $4.4M in total across 2 funding rounds.
Hedgehog MedTech has raised $4.4M across 2 funding rounds. Most recently, it raised $3.4M Series A in December 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2023 | $3.4M Series A | DBJ Capital, Yusuke Satake | D4V, Scrum Ventures, Shinsei Corporate Investment, SMBC Venture Capital | Announced |
| Nov 30, 2022 | $1.1M Seed | — | D4V, DBJ Capital, Keio Innovation Initiative, Scrum Ventures | Announced |
Hedgehog MedTech has raised $4.4M in total across 2 funding rounds.
Hedgehog MedTech's investors include DBJ Capital, Yusuke Satake, D4V, Scrum Ventures, Shinsei Corporate Investment, SMBC Venture Capital, Keio Innovation Initiative.